Works matching IS 02704137 AND DT 2022 AND VI 82 AND IP 14

Results: 10

Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy.

Published in:

Prostate, 2022, v. 82, n. 14, p. 1406, doi. 10.1002/pros.24414

By:

Hartrampf, Philipp E.;
Weinzierl, Franz‐Xaver;
Seitz, Anna Katharina;
Kübler, Hubert;
Essler, Markus;
Buck, Andreas K.;
Werner, Rudolf A.;
Bundschuh, Ralph A.

Publication type:

Article

Serum levels of chromogranin are not predictive of poorly differentiated prostate cancer: Results from a multicenter radical prostatectomy cohort.

Published in:

Prostate, 2022, v. 82, n. 14, p. 1400, doi. 10.1002/pros.24412

By:

Lombardo, Riccardo;
Rovesti, Lorenzo;
Cicione, Antonio;
Gravina, Carmen;
Franco, Antonio;
Stira, Jordi;
Simone, Giuseppe;
D'Annunzio, Simone;
Nacchia, Antonio;
Papalia, Rocco;
Mastroianni, Riccardo;
Collura, Devis;
Brassetti, Aldo;
Vecchione, Andrea;
Muto, Giovanni;
Gallucci, Michele;
Tubaro, Andrea;
De Nunzio, Cosimo

Publication type:

Article

Increased cytokine gene expression and cognition risk associated with androgen deprivation therapy.

Published in:

Prostate, 2022, v. 82, n. 14, p. 1389, doi. 10.1002/pros.24411

By:

Verma, Shiv;
Kushwaha, Prem Prakash;
Shankar, Eswar;
Ponsky, Lee E.;
Gupta, Sanjay

Publication type:

Article

Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5‐alpha reductase inhibitor treated human benign prostate hyperplasia patients.

Published in:

Prostate, 2022, v. 82, n. 14, p. 1378, doi. 10.1002/pros.24410

By:

Jin, Renjie;
Forbes, Connor;
Miller, Nicole L.;
Strand, Douglas;
Case, Thomas;
Cates, Justin M.;
Kim, Hye‐Young H.;
Wages, Phillip;
Porter, Ned A.;
Mantione, Krystin M.;
Burke, Sarah;
Mohler, James L.;
Matusik, Robert J.

Publication type:

Article

The 28th Annual Prostate Cancer Foundation Scientific Retreat report.

Published in:

Prostate, 2022, v. 82, n. 14, p. 1346, doi. 10.1002/pros.24409

By:

Miyahira, Andrea K.;
Soule, Howard R.

Publication type:

Article

A Phase II prospective study of hypofractionated proton therapy of prostate and pelvic lymph nodes: Acute effects on patient‐reported quality of life.

Published in:

Prostate, 2022, v. 82, n. 14, p. 1338, doi. 10.1002/pros.24408

By:

Wong, William W.;
Hillman, David W.;
Daniels, Thomas B.;
Vargas, Carlos E.;
Rwigema, Jean Claude;
Corbin, Kimberly S.;
Keole, Sameer R.;
Merrell, Kenneth W.;
Stish, Bradley J.;
Pisansky, Thomas M.;
Davis, Brian J.;
Mitchell, Cecilia M.;
Choo, Richard

Publication type:

Article

Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.

Published in:

Prostate, 2022, v. 82, n. 14, p. 1331, doi. 10.1002/pros.24407

By:

Casadó‐Llombart, Sergi;
Ajami, Tarek;
Consuegra‐Fernández, Marta;
Carreras, Esther;
Aranda, Fernando;
Armiger, Noelia;
Alcaraz, Antonio;
Mengual, Lourdes;
Lozano, Francisco

Publication type:

Article

Does castration status affect docetaxel‐related adverse events? :Identification of risk factors for docetaxel‐related adverse events in metastatic prostate cancer.

Published in:

Prostate, 2022, v. 82, n. 14, p. 1322, doi. 10.1002/pros.24406

By:

Yanagisawa, Takafumi;
Kimura, Takahiro;
Hata, Kenichi;
Narita, Shintaro;
Hatakeyama, Shingo;
Enei, Yuki;
Atsuta, Mahito;
Mori, Keiichiro;
Obayashi, Koki;
Yoshihara, Kentaro;
Kondo, Yosuke;
Oguchi, Takahiro;
Sadakane, Ibuki;
Habuchi, Tomonori;
Ohyama, Chikara;
Shariat, Shahrokh F.;
Egawa, Shin

Publication type:

Article

The state of PSA counseling in male‐to‐female transgender patients in the U.S.

Published in:

Prostate, 2022, v. 82, n. 14, p. 1315, doi. 10.1002/pros.24405

By:

Marthi, Siddharth;
O'Rourke, Timothy K.;
Tucci, Christopher;
Pareek, Gyan;
Hyams, Elias

Publication type:

Article

Issue Information.

Published in:: Prostate, 2022, v. 82, n. 14, p. 1313, doi. 10.1002/pros.24164
Publication type:: Article